The Boston-based startup is developing what executives hope will be more effective treatments for depression, anxiety, and ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...

The Company is investigating novel molecules within the CYB005 program at non-hallucinogenic doses for a range of Central Nervous System (“CNS”) disorders. In addition, the Company is continuing to ...

Highmark Health today announced initial results of Mental Well-Being powered by Spring Health, delivering significant ...

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...

ADHD is a behavioral disorder that affects attention, causes hyperactivity, and leads to impulsive actions. Anxiety is a ...

In recent years, ketamine has emerged as a groundbreaking treatment option for various mental health conditions, particularly ...

Healthline team member Heather Riesebeck has tried several treatments ... and more tame bursts of anxiety during the day. Another tester who has generalized anxiety disorder took them in the ...

Patrick Clancy’s wife killed their children during a postpartum mental-health crisis. Prosecutors describe a clear-headed ...

Supplementary insurance coverage for complementary health services (Yes) 202 55.0 Has a family physician (Yes) 308 83.5 Comorbid anxiety disorder (social anxiety disorder, panic disorder ...